Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI

SETTING: Nine months of daily isoniazid (9H) and 3 months of once-weekly rifapentine plus isoniazid (3HP) are recommended treatments for latent tuberculous infection (LTBI). The risk profile for 3HP and the contribution of hepatitis C virus (HCV) infection to hepatotoxicity are unclear. OBJECTIVES:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Tuberc Lung Dis
Asıl Yazarlar: Bliven-Sizemore, E. E., Sterling, T. R., Shang, N., Benator, D., Schwartzman, K., Reves, R., Drobeniuc, J., Bock, N., Villarino, M. E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5080618/
https://ncbi.nlm.nih.gov/pubmed/26260821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.14.0829
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller